Provided by Tiger Trade Technology Pte. Ltd.

NeuroPace Inc.

14.72
+0.16001.10%
Volume:226.26K
Turnover:3.31M
Market Cap:486.96M
PE:-19.55
High:15.17
Open:14.70
Low:14.40
Close:14.56
52wk High:18.98
52wk Low:7.56
Shares:33.08M
Float Shares:22.52M
Volume Ratio:1.34
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7530
EPS(LYR):-0.9318
ROE:-169.27%
ROA:-11.19%
PB:26.30
PE(LYR):-15.80

Loading ...

NeuroPace Reports Positive 18-Month Results from NAUTILUS Trial for Drug-Resistant Epilepsy

Reuters
·
Dec 08, 2025

Neuropace Unveils New Clinical Data and AI Tools for RNS System at AES 2025

Reuters
·
Dec 02, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco

Reuters
·
Nov 24, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials

Reuters
·
Nov 24, 2025

NeuroPace (NPCE) Gets a Buy from Lake Street

TIPRANKS
·
Nov 24, 2025

BUZZ-NeuroPace jumps as Medicare boosts pay for epilepsy device procedures

Reuters
·
Nov 24, 2025

NeuroPace Says Medicare Increases Reimbursement for RNS Procedures

MT Newswires Live
·
Nov 24, 2025

Neuropace Inc - Payment Rates Increased by Approximately 43% (+$530) for Initial Implant Procedure, 45% (+$260) for Replacement Procedure

THOMSON REUTERS
·
Nov 24, 2025

Neuropace Inc - Announces Favorable Medicare Reimbursement Increases

THOMSON REUTERS
·
Nov 24, 2025

3 Stocks Possibly Trading At A Discount Of Up To 37.8%

Simply Wall St.
·
Nov 21, 2025

NeuroPace Up Over 40%, On Pace for Record Percent Increase -- Data Talk

Dow Jones
·
Nov 06, 2025

NeuroPace Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 05, 2025

J.P. Morgan Reaffirms Their Buy Rating on NeuroPace (NPCE)

TIPRANKS
·
Nov 05, 2025

Neuropace Shares up 19.9% Premarket After Q3 REV Beats Estimates

THOMSON REUTERS
·
Nov 05, 2025

NeuroPace Reports Record Revenue and Raises Guidance

TIPRANKS
·
Nov 05, 2025

NeuroPace reports Q3 EPS (11c), consensus (19c)

TIPRANKS
·
Nov 05, 2025

NeuroPace Q3 EPS $(0.11) Beats $(0.19) Estimate, Sales $27.354M Beat $24.634M Estimate

Benzinga
·
Nov 05, 2025

BRIEF-NeuroPace, Inc. Q3 EPS USD -0.11

Reuters
·
Nov 05, 2025

Neuropace, Inc. Q3 EPS USD -0.11

THOMSON REUTERS
·
Nov 05, 2025

Neuropace, Inc. Outlook FY Gross Margin 76-77%

THOMSON REUTERS
·
Nov 05, 2025